Business Description
LifeStance Health Group, Inc. specializes in delivering outpatient mental healthcare services through its subsidiary network. The company offers a comprehensive array of mental health solutions, encompassing psychiatric evaluations and treatment, specialized psychological and neuropsychological testing, and diverse therapeutic modalities including individual, family, and group therapy sessions. The organization addresses a wide spectrum of mental health conditions, ranging from common issues like anxiety and depression to more complex challenges such as bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. Patients have access to care through various channels: virtually via its online platform or in-person at its many centers located throughout 32 states. LifeStance is dedicated to supporting individuals across all age groups, providing care for children, adolescents, adults, and the elderly. LifeStance Health Group, Inc. was founded in 2017 and its main offices are situated in Scottsdale, Arizona.
Business History
Price Overview
Last updated: Jun 27, 2026 10:07am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 0.03
Total Equity: $1.52B
Shares: 391,136,000
Total Debt: $194.10M
Cash: $248.64M
EBITDA: $78.78M
Total Debt: $194.10M
Cash: $248.64M
Revenue: $1.42B
Revenue: $1.42B
Revenue: $1.42B
Total Equity: $1.52B
Tax Rate: 21.8%
Equity: $1.52B
Total Debt: $194.10M
Cash: $248.64M
Current Liabilities: $251.96M
Long-Term Debt: $148.55M
Total Debt: $194.10M
Total Equity: $1.52B
Shares: 391,136,000
Shares: 391,136,000
CapEx: -$36.13M
Shares: 391,136,000
Stock Price: $10.28
Net Income: $9.66M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 22, 2026 8:53pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $667.5M | $859.5M | $1.1B | $1.3B | $1.4B |
| Cost of Revenue | $466.0M | $622.5M | $753.6M | $848.6M | $963.2M |
| Gross Profit | $201.5M | $237.0M | $302.1M | $402.4M | $461.1M |
| Operating Expenses | $487.9M | $447.2M | $491.2M | $434.0M | $437.0M |
| Operating Income | -$286.4M | -$210.2M | -$189.1M | -$31.6M | $24.1M |
| Net Income | -$307.2M | -$215.6M | -$186.3M | -$57.4M | $9.7M |
| EBITDA | -$240.1M | -$143.6M | -$104.9M | $39.9M | $78.8M |
| EPS | $-1.05 | $-0.61 | $-0.51 | $-0.15 | $0.03 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 22, 2026 8:53pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $148.0M | $108.6M | $78.8M | $154.6M | $248.6M |
| Total Current Assets | $266.5M | $233.2M | $225.7M | $312.5M | $416.2M |
| Total Assets | $1.9B | $2.2B | $2.1B | $2.1B | $2.2B |
| Current Liabilities | $116.8M | $176.0M | $202.9M | $228.9M | $252.0M |
| Long-Term Debt | $157.4M | $225.1M | $280.3M | $279.8M | $148.6M |
| Total Liabilities | $382.1M | $655.1M | $681.0M | $672.0M | $682.9M |
| Total Equity | $1.5B | $1.5B | $1.4B | $1.4B | $1.5B |
| Retained Earnings | -$357.1M | -$572.6M | -$760.8M | -$818.3M | -$808.6M |
Cash Flow (Annual)
Last updated: Jun 22, 2026 8:53pm (4d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $9.4M | $52.8M | -$16.9M | $107.3M | $146.2M |
| Capital Expenditure | -$94.5M | -$79.3M | -$40.5M | -$21.6M | -$36.1M |
| Free Cash Flow | -$85.1M | -$26.5M | -$57.4M | $85.7M | $110.0M |
| Acquisitions (net) | -$99.6M | -$60.2M | -$19.8M | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $-904,000 | $0 | $0 | $0 |
| Net Change in Cash | $129.2M | -$39.4M | -$29.8M | $75.7M | $94.1M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 9:04am (1h ago)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$1.4B $1.4B – $1.4B
|
$1.7B $1.6B – $1.7B
|
$1.9B $1.9B – $1.9B
|
$2.2B $2.2B – $2.2B
|
| EBITDA |
$571.2M $564.5M – $580.4M
|
$669.1M $661.0M – $673.1M
|
$762.4M $750.2M – $774.5M
|
$872.6M $871.7M – $873.5M
|
| Net Income |
-$1.7M -$1.7M – -$1.7M
|
$55.7M $44.4M – $62.1M
|
$76.2M $70.6M – $81.8M
|
$162.2M $138.2M – $186.2M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 22, 2026 8:53pm (4d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +28.8% | +22.8% | +18.5% | +13.9% |
| Gross Profit Growth | +17.6% | +27.5% | +33.2% | +14.6% |
| Operating Income Growth | +26.6% | +10.0% | +83.3% | +176.4% |
| Net Income Growth | +29.8% | +13.6% | +69.2% | +116.8% |
| EBITDA Growth | +40.2% | +26.9% | +138.0% | +97.6% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 9:04am (1h ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-11 | Paunovich Vukasin | F-InKind | 17,456.00 | $8.61 | $150,296 |
| 2026-05-12 | Bessler Robert | S-Sale | 287,517.00 | $8.02 | $2.3M |
| 2026-05-12 | Bessler Robert | S-Sale | 287,517.00 | $8.02 | $2.3M |
| 2026-05-12 | Shuey Eric | S-Sale | 243,362.00 | $8.02 | $2.0M |
| 2026-05-12 | BLACK DARREN M. | S-Sale | 5,899,661.00 | $8.02 | $47.3M |
| 2026-05-12 | TPG GP A, LLC | S-Sale | 28,281,943.00 | $8.02 | $226.8M |
| 2026-05-07 | Bessler Robert | S-Sale | 37,500.00 | $8.55 | $320,625 |
| 2026-05-07 | Bessler Robert | S-Sale | 37,500.00 | $8.55 | $320,625 |
| 2026-04-23 | Bessler Robert | S-Sale | 3,876.00 | $7.00 | $27,132 |
| 2026-04-24 | Bessler Robert | S-Sale | 31,074.00 | $7.05 | $219,072 |
| 2026-04-23 | Bessler Robert | S-Sale | 3,876.00 | $7.00 | $27,132 |
| 2026-04-24 | Bessler Robert | S-Sale | 31,073.00 | $7.05 | $219,065 |
| 2026-04-21 | Bessler Robert | S-Sale | 2,550.00 | $7.01 | $17,876 |
| 2026-04-21 | Bessler Robert | S-Sale | 2,551.00 | $7.01 | $17,883 |
| 2026-04-01 | Pardo Ryan | F-InKind | 9,376.00 | $6.37 | $59,725 |
| 2026-03-24 | McGroarty Ryan | F-InKind | 24,255.00 | $6.45 | $156,445 |
| 2026-03-17 | McGroarty Ryan | F-InKind | 47,594.00 | $6.89 | $327,923 |
| 2026-03-09 | Burdick Kenneth A | A-Award | 706,960.00 | $0.00 | $0 |
| 2026-03-09 | Burdick Kenneth A | F-InKind | 278,192.00 | $6.91 | $1.9M |
| 2026-03-09 | Burdick Kenneth A | A-Award | 33,544.00 | $0.00 | $0 |
Narrative Economics
market-narrative step).